BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rare Diseases International - ECPv6.2.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rare Diseases International
X-ORIGINAL-URL:https://www.rarediseasesinternational.org
X-WR-CALDESC:Events for Rare Diseases International
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250212T090000
DTEND;TZID=UTC:20250212T170000
DTSTAMP:20260612T045647
CREATED:20250131T061408Z
LAST-MODIFIED:20250131T061408Z
UID:10000370-1739350800-1739379600@www.rarediseasesinternational.org
SUMMARY:3rd Brazilian Health Technology Assessment (HTA) Forum for Rare Diseases
DESCRIPTION:Instituto Unidos Pela Vida will host the 3rd Brazilian Health Technology Assessment (HTA) Forum for Rare Diseases on February 12\, from 9:00 AM to 5:00 PM\, BRT. The event will take place at Blue Tree Premium Morumbi in São Paulo\, Brazil\, and will also be available online via the Congresse.me platform. \nThe forum aims to provide a platform for discussing Health Technology Assessment (HTA) processes\, with a special focus on rare diseases. It will explore the importance of monitoring\, the challenges involved\, and ways to empower the rare disease community to actively participate in social engagement opportunities.The event will be hosted and moderated by Verônica Stasiak Bednarczuk\, founder and executive director of Unidos pela Vida\, alongside organization directors Marise Basso Amaral and Cristiano Silveira. The Forum will feature simultenous translation into Brazilian sign language\, English\, and Spanish. Register here.
URL:https://www.rarediseasesinternational.org/event/3rd-brazilian-health-technology-assessment-hta-forum-for-rare-diseases/
CATEGORIES:Hosted by RDI Member
ATTACH;FMTTYPE=image/png:https://www.rarediseasesinternational.org/wp-content/uploads/2025/01/English-Feed.png
END:VEVENT
END:VCALENDAR